Impaired kidney structure and function in spinal muscular atrophy

Area of Science:

• Nephrology
• Neuromuscular Disorders
• Genetics

Background:

• Spinal muscular atrophy (SMA) type 1 is a severe genetic neuromuscular disorder.
• Systemic manifestations of SMA, particularly renal involvement, are not fully understood.

Purpose of the Study:

• To investigate renal structure and function in patients with SMA type 1.
• To compare serum profiles and kidney tissue characteristics between SMA type 1 patients and controls.

Main Methods:

• Cohort study comparing infants and children with SMA type 1 to age- and sex-matched controls.
• Analysis of serum creatinine, cystatin C, electrolytes, glucose, and calcium.
• Examination of urine for casts and crystals.
• Kidney tissue analysis including PCR arrays and immunoblotting for specific proteins.

Main Results:

• SMA patients exhibited altered serum creatinine, cystatin C, sodium, glucose, and calcium.
• Urine analysis revealed granular casts and crystals; kidney biopsies showed nephrocalcinosis and fibrosis.
• Kidney tissue demonstrated differential gene expression and altered levels of calcium-sensing receptors, calbindin, and IGF-binding proteins.

Conclusions:

• Patients with SMA type 1 frequently show impaired renal function, potentially as a primary or secondary disease consequence.
• These findings highlight systemic contributions of SMA to disease pathogenesis.
• The study underscores the need for coadjuvant therapies to address renal complications in SMA.